Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04007588
Brief Title: A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma

First Submitted : July 1, 2019
First Submitted that Met QC Criteria : July 1, 2019
First Posted : July 5, 2019

Last Update Submitted that Met QC Criteria : February 3, 2020
Last Update Posted : February 5, 2020